Nanotechnology is no small matter in the Mid-Atlantic region
of the United States. Rich in academic, scientific and corporate
resources, the region is well poised to move the promise of
new materials and medicines from the lab to the marketplace.
Today, these scientific breakthroughs to commercial applications
are unfolding in a variety of areas in the tri-state region
- from the development of lightweight army fatigues that resist
chemical weapons to portable labs that provide instant analysis
for everything from diabetes to HIV. And it's all happening
in the Mid-Atlantic Region - more specifically in Pennsylvania,
New Jersey and Delaware.
MANA: The Mid-Atlantic Nanotechnology Alliance is a collaboration
to develop and position the tri-state region as a global
hub for the expanded research, development, application
and commercialization of nanotechnology. Its primary purpose
is to facilitate a multi-state partnership through:
- Securing and attracting funding for research, development
and commercialization of nanotechnology;
- Developing and disseminating information and knowledge
including best practices, policy & planning, informed
investment, and emerging opportunities; and
- Positioning the region with a unified message, developing
critical mass and showcasing its diverse strengths.
MANA was formed in the fall of 2004 and is funded by the
U.S. Department of Commerce Economic Development Administration
(EDA). MANA is the catalyst to the region's transformation
with a mission to build the critical infrastructure needed
to translate today's emerging nanotechnology developments
into practical applications that spur economic development
for the Mid-Atlantic region.